Compare · RLX vs USNA
RLX vs USNA
Side-by-side comparison of RLX Technology Inc. (RLX) and USANA Health Sciences Inc. (USNA): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both RLX and USNA operate in Medicinal Chemicals and Botanical Products (Health Care), so they compete in similar markets.
- RLX is the larger of the two at $2.77B, about 10.9x USNA ($254.6M).
- USNA has been more active in the news (5 items in the past 4 weeks vs 4 for RLX).
- USNA has more recent analyst coverage (3 ratings vs 2 for RLX).
- Company
- RLX Technology Inc.
- USANA Health Sciences Inc.
- Price
- -
- -
- Market cap
- $2.77B
- $254.6M
- 1M return
- -12.04%
- -
- 1Y return
- -25.10%
- -
- Industry
- Medicinal Chemicals and Botanical Products
- Medicinal Chemicals and Botanical Products
- Exchange
- NYSE
- NYSE
- IPO
- 2021
- News (4w)
- 4
- 5
- Recent ratings
- 2
- 3
RLX Technology Inc.
RLX Technology Inc., together with its subsidiaries, researchers, develops, manufactures, distributes, and sells e-vapor products in the People's Republic of China. It serves RELX branded partner stores and other retail outlets through distributors. RLX Technology Inc. was founded in 2018 and is based in Beijing, China.
USANA Health Sciences Inc.
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional and personal care products. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include meal replacement shakes, snack bars, and other related products, which provide macro-nutrition. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products directly in the Asia Pacific, the Americas, and Europe, as well as online. The company has a research collaboration agreement with Beijing University of Chinese Medicine for research in the field of traditional Chinese medicine. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.
Latest RLX
- SEC Form 6-K filed by RLX Technology Inc.
- RLX Technology Announces Unaudited Second Quarter 2026 Financial Results
- RLX Technology to Report Second Quarter 2026 Financial Results on August 14, 2026
- SEC Form 4 filed by Chief Financial Officer Lu Chao
- SEC Form 6-K filed by RLX Technology Inc.
- RLX Technology Announces Unaudited First Quarter 2026 Financial Results
- RLX Technology to Report First Quarter 2026 Financial Results on May 20, 2026
- RLX Technology Files 2025 Annual Report on Form 20-F
- SEC Form 20-F filed by RLX Technology Inc.
- SEC Form 3 filed by new insider Wang Ying Kate
Latest USNA
- USANA Introduces 3-in-1 Protein, Creatine, and Electrolyte Drink Mix
- SEC Form 10-Q filed by USANA Health Sciences Inc.
- USANA Chairman, CEO Kevin Guest Shares 5 Ways to Make Happiness Happen at Work and Home This August
- USANA Health Sciences Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
- USANA Health Sciences Reports Second Quarter 2026 Results
- New 12-Week Consumer Study Highlights Visible Skin Benefits with USANA Glow
- CHIEF INFORMATION OFFICER Benedict Peter converted options into 598 shares and covered exercise/tax liability with 176 shares (SEC Form 4)
- CHIEF SCIENTIFIC OFFICER Armstrong Kathryn Michelle converted options into 1,166 shares and covered exercise/tax liability with 518 shares, increasing direct ownership by 23% to 3,471 units (SEC Form 4)
- Director Wood Timothy E converted options into 1,632 shares and covered exercise/tax liability with 408 shares, increasing direct ownership by 12% to 11,837 units (SEC Form 4)
- Director Winssinger Frederic J converted options into 1,632 shares, increasing direct ownership by 20% to 9,733 units (SEC Form 4)